{
    "Trade/Device Name(s)": [
        "OSOM Influenza A&B Test"
    ],
    "Submitter Information": "Genzyme Corporation",
    "510(k) Number": "K061508",
    "Predicate Device Reference 510(k) Number(s)": [
        "K051244"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "June 12, 2006",
    "Summary Letter Received Date": "June 1, 2006",
    "Submission Date": "May 31, 2006",
    "Regulation Number(s)": [
        "21CFR866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza Virus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "virology"
    ],
    "Analyte(s)": [
        "Influenza A viral nucleoprotein antigen",
        "Influenza B viral nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasal swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for OSOM Influenza A&B Test, a lateral flow immunochromatographic assay for qualitative detection of influenza A and B viral nucleoprotein antigens from nasal swabs.",
    "Indications for Use Summary": "Qualitative detection of influenza A and B viral nucleoprotein antigens from nasal swab specimens in symptomatic patients to aid in rapid differential diagnosis of influenza A and/or B infections; negative results are presumptive and should be confirmed by cell culture.",
    "fda_folder": "Microbiology"
}